11-12 May 2017: Defymed will be present at the JDRF Encapsulation Consortium that will be held in New York – USA. Defymed will present the latest results on MailPan®’s Bioartificial Pancreas development. This privileged group gathers worldwide key opinion leaders in the field of Cell therapy and Encapsulation for the treatment of Type1 Diabetes. For more info.